Quick Answer
STANDARD BIOTOOLS INC. reported Revenue (ASC 606) of $85.33 million for fiscal year 2025.
STANDARD BIOTOOLS INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $85.33M | -6.2% |
| 2024 | $91.01M | -14.4% |
| 2023 | $106.34M | +8.6% |
| 2022 | $97.95M | -25.0% |
| 2021 | $130.58M | -5.5% |
| 2020 | $138.14M | +17.8% |
| 2019 | $117.24M | +3.8% |
| 2018 | $112.96M | +10.8% |
| 2017 | $101.94M | -2.4% |
| 2016 | $104.45M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $19.55M | -11.5% | -10.2% |
| June 30, 2025 | $21.76M | -3.2% | -46.7% |
| March 31, 2025 | $40.80M | -10.4% | +84.7% |
| September 30, 2024 | $22.09M | -12.9% | -1.8% |
| June 30, 2024 | $22.49M | -18.7% | -50.6% |
| March 31, 2024 | $45.54M | +81.3% | +79.5% |
| September 30, 2023 | $25.37M | -1.1% | -8.3% |
| June 30, 2023 | $27.67M | +47.3% | +10.1% |
- STANDARD BIOTOOLS INC. showed a decrease of -6.2% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, STANDARD BIOTOOLS INC.’s revenue (asc 606) has declined by 18.3% (from $104.45 million to $85.33 million).
- The most recent figure is from STANDARD BIOTOOLS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: